A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease
type: MedicalStudy
description: A Randomised Double-blind Placebo-controlled Clinical Study Investigating the Effects of Semaglutide s.c. Once-weekly Versus Placebo on Central and Peripheral Inflammation in Participants With Alzheimer's Disease
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE3
start date: 2023-06-20
end date: 2025-09-08
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT05891496
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Novo Nordisk A/S
study subject: Alzheimers Disease
keywords: PHASE3
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Alzheimers Disease

AI Analytics
type: Organization